TREN
Contact us

Deducting health expenditures for a spouse in the return under ITL Art. 89/2

Personal Income Tax · Deductions from incomeDeducting health expenditures for a spouse in the return under ITL Art. 89/2Private ruling · 24 April 2024
Rast note

A taxpayer asked whether two expenditures for his/her spouse (an intrauterine device for birth control applied at a hospital and a vitamin application to the face by injection performed by a doctor) can be deducted in the annual income tax return.

The Administration's view:

  • Under ITL Art. 89/1-2, health expenditures in the diagnosis/treatment process for the taxpayer, spouse and minor children are deductible up to 10% of declared income, subject to the conditions.
  • The intrauterine device application for birth control is a health expenditure and can be deducted, provided it is not deducted twice.
  • The vitamin application to the face by injection is not a health expenditure and cannot be deducted.

The ruling is relevant to taxpayers filing returns and seeking a health expenditure deduction.

ShareLinkedInWhatsAppEmail

Full text

Subject: Whether health expenditures can be deducted in the annual income tax return
Unofficial translation by Rast Partners. The Turkish original published by the Revenue Administration prevails.

In the ruling request form referred to above, it is understood that you request information on whether health expenditures for your spouse, shown on an invoice issued by a hospital for the application of an intrauterine device for birth control and on a self-employment receipt issued by a doctor for a vitamin application to the face (skin) by injection, can be deducted in the annual income tax return. Our Administration's opinion is set out below.

Article 70 of Income Tax Law No. 193, titled "Definition of Income from Immovable Capital", defines income from immovable capital as income earned from leasing the property and rights listed in that article by their owners, possessors, holders, easement and usufruct holders or tenants.

Article 89 of the same Law, titled "Other Deductions", provides:

"In determining the income tax base, the following deductions may be made from the income to be declared in the income tax return.
...
2. Education and health expenditures made for the taxpayer, spouse and minor children, provided they do not exceed 10% of declared income, are made in Turkey and are documented with documents obtained from individuals or legal entities subject to income or corporate tax (wage earners benefiting from tax reduction for education and health expenditures under Repeated Article 121 cannot deduct the same expenditures from their base under this provision)."

Section "Health Expenses" of General Communiqué on Income Tax Serial No. 255 states:

"Health expenditures made in the diagnosis and/or treatment process (such as examination, analysis, surgery, physiotherapy and hospital expenses and purchases of medicines, medical supplies, glasses and lenses) will be subject to tax deduction."

In this framework, your expenditures for the intrauterine device application for birth control for your spouse will be accepted as health expenditures and, provided they are not deducted twice, can be deducted in determining your income tax base under Article 89/1-2 of the Income Tax Law.

On the other hand, since your expenditures for the vitamin application to the face (skin) by injection cannot be regarded as health expenditures, they cannot be deducted in determining your income tax base.

Kindly be informed.

(*) This ruling has been issued under Article 413 of Tax Procedure Law No. 213.
(**) This ruling is invalid if incorrect information has been provided on this matter while it is under tax examination, judicial review or settlement.
(***) If you act in accordance with this ruling issued at your request and tax has to be assessed as a result, no tax penalty will be imposed on you and no late payment interest will be calculated on the tax assessed.

Private rulings bind only the taxpayer who requested them; similar cases should be assessed separately. The English text is an unofficial translation prepared by Rast Partners; the Turkish original published by the Revenue Administration prevails.